0001415889-21-004613.txt : 20210929
0001415889-21-004613.hdr.sgml : 20210929
20210929195653
ACCESSION NUMBER: 0001415889-21-004613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210927
FILED AS OF DATE: 20210929
DATE AS OF CHANGE: 20210929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bohen Sean
CENTRAL INDEX KEY: 0001831218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 211293137
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
form4-09292021_040935.xml
X0306
4
2021-09-27
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001831218
Bohen Sean
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
true
true
false
false
PRESIDENT AND CEO
Common Stock
2021-09-27
4
M
0
1085
4.824
A
53599
D
Common Stock
2021-09-27
4
S
0
1085
30.07
D
52514
D
Stock Option (Right to Buy)
4.824
2021-09-27
4
M
0
1085
0
D
2030-11-18
Common Stock
1085
971316
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2021-09-28